MOXIVIG

This brand name is authorized in United Kingdom

Active ingredients

The drug MOXIVIG contains one active pharmaceutical ingredient (API):

1 Moxifloxacin UNII C53598599T - MOXIFLOXACIN HYDROCHLORIDE

Moxifloxacin, a fourth-generation fluoroquinolone, has in vitro activity against a wide range of Gram-positive and Gram-negative pathogens. The bactericidal action of moxifloxacin results from the inhibition of both type II topoisomerases (DNA gyrase and topoisomerase IV) required for bacterial DNA replication, transcription and repair. Read about Moxifloxacin

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
MOXIVIG Eye drops	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
S01AE07		S Sensory organs → S01 Ophthalmologicals → S01A Antiinfectives → S01AE Fluoroquinolones
Discover more medicines within S01AE07

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 184831